Results 21 to 30 of about 41,304 (260)

The new, direct, target-specific oral anticoagulants

Journal of Applied Hematology, 2015
In recent years, numerous alternatives to VKAs have been developed, the first competitors to warfarin are the novel oral anticoagulants (NOAC) or better referred to as Direct Oral Anti-Coagulant (DOAC) or Target Specific Oral Anti-coagulant (TSOAC ...
Nevine A Kassim
doaj   +1 more source

Direct oral anticoagulant reversal: An update

Nursing, 2020
Abstract: The rise in direct oral anticoagulant (DOAC) use means nurses must understand the reversal of these agents in case of bleeding. Depending on bleed severity, as well as other criteria, pharmacologic reversal can be considered in place of supportive care alone. Knowledge of literature surrounding DOAC reversal is crucial.
Andrea, Hafer, Lindsay, McCann
openaire   +3 more sources

Use of New Oral Anticoagulants/ Direct Oral Anticoagulants in Malignant Patients [PDF]

Cureus, 2020
Vitamin K antagonists are being used in the last five decades as an effective anticoagulant. However, for the past few years, new oral anticoagulants (NOACs) have been introduced as newer anticoagulant agents, which are gradually replacing the previously used vitamin K antagonist.
Khan, Yusra, Zaidi, Syed Owais, Razak, Bibi S, Zaki, Mariann, Malik, Bilal Haider   +4 more
openaire   +2 more sources

Performing diagnostic radial access coronary angiography on uninterrupted direct oral anticoagulant therapy: a prospective analysis

Open Heart, 2019
Purpose We sought to assess the safety of performing diagnostic radial access coronary angiography with uninterrupted anticoagulation on patients receiving direct oral anticoagulant therapy.Background Direct oral anticoagulants have become a popular ...
Napohn Chongprasertpon, Samer Arnous, Thomas John Kiernan, Aiste Zebrauskaite, John Joseph Coughlan, Abdalla Ibrahim, Terence Hennessy   +6 more
doaj   +1 more source

Direct Oral Anticoagulants and Women

Seminars in Thrombosis and Hemostasis, 2016
Direct oral anticoagulants (DOACs) provide an effective, safe, and convenient therapeutic alternative to warfarin and other vitamin K antagonists (VKAs), and are now established for a wide range of indications. The use of DOACs in women merits special consideration due to two main situations: first, in relation to fertility, pregnancy, and lactation in
Cohen, Hannah, Arachchillage, Deepa R. J., Beyer-Westendorf, Jan, Middeldorp, Saskia, Kadir, Rezan A.   +4 more
openaire   +2 more sources

Bleeding on oral anticoagulants: overview of reversal strategies

Swiss Medical Weekly, 2023
Oral anticoagulants (antivitamin K, direct oral anticoagulants) are routinely prescribed for the prevention or treatment of thromboembolic events, and many patients are now on long-term anticoagulant therapy.
Mauro Foletti, Thomas Schmutz, Yvan Fleury, Jean-Luc Magnin, Christophe Le Terrier, Youcef Guechi   +5 more
doaj   +1 more source

Direct oral anticoagulant use in left ventricular thrombus

Thrombosis Journal, 2020
Left ventricular thrombus (LVT) is associated with a significant risk of ischemic stroke (IS) and peripheral embolization. Societal guidelines recommend the use of warfarin, with direct oral anticoagulants (DOACs) only for patients unable to tolerate ...
Zafar Ali, Nicholas Isom, Tarun Dalia, Farhad Sami, Uzair Mahmood, Zubair Shah, Kamal Gupta   +6 more
doaj   +1 more source

Direct Oral Anticoagulants

JACC: Cardiovascular Interventions, 2014
This chapter reviews the new direct oral anticoagulants—thrombin inhibitor and Xa inhibitors. The specific drugs are reviewed as well as the specific indications—prevention and treatment of deep venous thrombosis, stroke prevention in atrial fibrillation, and then acute coronary syndrome.
Levy, Jerrold H., Spyropoulos, Alex C., Samama, Charles M., Douketis, James   +3 more
openaire   +2 more sources

Direct oral anticoagulant: Looking beyond convenience

Annals, Academy of Medicine, Singapore
Since the 2010 Food and Drug Administration approval of Dabigatran as the first non-vitamin-K antagonist oral anticoagulants or direct oral anticoagulants (DOACs) as it is now more commonly referred to, there has been much development in the field with ...
Samuel Ji Quan Koh, Jonathan Jiunn Liang Yap   +1 more
doaj   +1 more source

Direct oral anticoagulant blood level monitoring in daily practice

Thrombosis Update, 2021
Introduction: Routine monitoring is not required in direct oral anticoagulant (DOAC) treatment, yet it is frequently performed. Guidance on the interpretation and management of DOAC level measurements is lacking and it is key to investigate which ...
R. Bavalia, J.E. Veenhuizen, R.C.C. Hengeveld, D. Braeken, A.J.W. Gulpen, H. Ten Cate, S. Middeldorp, Y.M.C. Henskens, B.A. Hutten, M. Coppens, A.K. Stroobants   +10 more
doaj   +1 more source